Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745883 · ClinicalTrials.gov registry record · Phase 1
Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
A Phase 1 study of Chronic Kidney Diseases and Anemia of Chronic Kidney Disease, sponsored by Disc Medicine.
- Active
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 13
- Study locations
NCT05745883 is a Phase 1 study of Chronic Kidney Diseases and Anemia of Chronic Kidney Disease that is active but no longer recruiting, run by Disc Medicine. The registered enrollment target is 50 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (89% lower). The trial reports 13 study locations across 10 states.
The verdict
NCT05745883, a Phase 1 study of Chronic Kidney Diseases and Anemia of Chronic Kidney Disease, is active but no longer recruiting, sponsored by Disc Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 13
- Study locations
Study Summary
This Phase 1b study of DISC-0974 will assess the safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney Disease and Anemia.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG DISC-0974
Study Locations (13)
Florida
- Accel Research - DeLand
- Total Research Group - Miami
- Flourish Research - Winter Park
Texas
- Clinical Advancement Center, PLLC - San Antonio
- Endeavor Clinical Trials - San Antonio
California
- UCLA Clinical and Translational Research - Los Angeles
Colorado
- US Renal Care Inc. - Lone Tree
Georgia
- Nephrology and Hypertension Specialists, PC-Dalton - Dalton
Idaho
- CARE Institute - Boise Kidney - Boise
Michigan
- Center for Advanced Kidney Research PLC - Saint Clair Shores
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2026-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05745883
The ClinicalTrials.gov registry entry for NCT05745883 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (89% lower). The listed sponsor is Disc Medicine, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05745883 reports 13 study locations spanning 10 distinct geographic areas - top geographies include Florida, Texas, California.
Frequently Asked Questions
What is clinical trial NCT05745883 about?
NCT05745883 is a clinical study titled "Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia". This Phase 1b study of DISC-0974 will assess the safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney Disease and Anemia.
What is the current status of trial NCT05745883?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2023-04-04. Estimated completion is 2026-05.
What conditions does trial NCT05745883 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Anemia of Chronic Kidney Disease.
What interventions are being tested in trial NCT05745883?
The interventions under investigation include: Placebo (DRUG), DISC-0974 (DRUG).
Who is sponsoring clinical trial NCT05745883?
This trial is sponsored by Disc Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05745883 being conducted?
This trial has 13 study locations across California, Colorado, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
RECRUITING · Phase 1
-
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
RECRUITING · Phase 1
-
Immunological Tolerance in Patients With Mismatched Kidney Transplants
ACTIVE NOT RECRUITING · Phase 1
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.